- Home
- SCNI vs APDN Comparison
SCNI vs APDN Comparison
Compare SCNI & APDN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SCNI
- APDN
- Stock Information
- Founded
- SCNI 2003
- APDN 1983
- Country
- SCNI Israel
- APDN United States
- Employees
- SCNI N/A
- APDN N/A
- Industry
- SCNI Biotechnology: Biological Products (No Diagnostic Substances)
- APDN Other Consumer Services
- Sector
- SCNI Health Care
- APDN Consumer Discretionary
- Exchange
- SCNI Nasdaq
- APDN Nasdaq
- Market Cap
- SCNI 1.9M
- APDN 2.0M
- IPO Year
- SCNI N/A
- APDN N/A
- Fundamental
- Price
- SCNI $2.55
- APDN $0.84
- Analyst Decision
- SCNI
- APDN Strong Buy
- Analyst Count
- SCNI 0
- APDN 1
- Target Price
- SCNI N/A
- APDN $75.00
- AVG Volume (30 Days)
- SCNI 18.0K
- APDN 1.5M
- Earning Date
- SCNI 05-14-2025
- APDN 05-09-2025
- Dividend Yield
- SCNI N/A
- APDN N/A
- EPS Growth
- SCNI N/A
- APDN N/A
- EPS
- SCNI 8.20
- APDN N/A
- Revenue
- SCNI $452,000.00
- APDN $3,736,873.00
- Revenue This Year
- SCNI N/A
- APDN $57.08
- Revenue Next Year
- SCNI N/A
- APDN $40.00
- P/E Ratio
- SCNI $0.30
- APDN N/A
- Revenue Growth
- SCNI N/A
- APDN N/A
- 52 Week Low
- SCNI $1.90
- APDN $0.72
- 52 Week High
- SCNI $8.92
- APDN $246.00
- Technical
- Relative Strength Index (RSI)
- SCNI 45.49
- APDN 22.16
- Support Level
- SCNI $1.90
- APDN $0.82
- Resistance Level
- SCNI $2.54
- APDN $0.95
- Average True Range (ATR)
- SCNI 0.29
- APDN 0.15
- MACD
- SCNI 0.04
- APDN 0.17
- Stochastic Oscillator
- SCNI 47.71
- APDN 13.34
About SCNI Scinai Immunotherapeutics Ltd.
Scinai Immunotherapeutics Ltd is a biopharmaceutical company focused on developing, manufacturing and commercializing products for the prevention and treatment of infectious diseases and other illnesses. It has executed eight clinical trials in seven countries, around 12,400 participants in the Phase 3 trial of its vaccine candidate and has built a GMP biologics manufacturing facility for biopharmaceutical products. The company is aiming to develop a pipeline of diversified and commercially viable products and platforms beginning with a nanosized antibody (NanoAb) pipeline.
About APDN Applied DNA Sciences Inc.
Applied DNA Sciences Inc is a biotechnology company developing and commercializing technologies to produce and detect deoxyribonucleic acid (DNA) and ribonucleic acid (RNA). The company operates in three business segments- Therapeutic DNA Production Services, MDx Testing Services, and DNA Tagging and Security Products and Services. It generates majority of its revenue from the MDx Testing Services which is involved in performing and developing clinical molecular diagnostic and genetic tests and clinical laboratory testing services. The company provides its products and services under the brand of Applied DNA Sciences, SigNature molecular tags, SigNature T molecular tags, fiberTyping, SigNify and others.